BeiGene (NASDAQ:BGNE) Stock Quotes, Forecast and News Summary

Q: What sector and industry does BeiGene (BGNE) operate in?

BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BeiGene Stock (NASDAQ: BGNE) stock price, news, charts, stock research, profile.

Open	$156.12
Close	-
Volume / Avg.	62.57K / 208.71K
Day Range	155.30 - 159.61
52 Wk Range	126.97 - 225.23
Market Cap	$16.86B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	-
Days to Cover	8.01

Recent News

Moderna And Walgreens Boots Alliance Were Among The 10 Biggest Large Cap Losers Last Week (June 23 - June 29): Are These In Your Portfolio?

10 worst performing large-cap stocks last week: Walgreens, Floor & Decor, Moderna, Birkenstock, BeiGene, Pool Corp, JD.com, Ecopetrol, International Paper, Micron.

Lekha Gupta

What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?

Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-5948 showed promising safety and efficacy in Phase 1a/b trials for relapsed/refractory B-cell malignancies

Vandana Singh

Lululemon Athletica Was Among The Worst-Performing Stocks Last Week (May 19-May 26, 2024): Are These 10 Large-Cap Stock Losers In Your Portfolio?

10 worst-performing large-cap stocks last week. National Grid, James Hardie, KE Holdings, JD.Com, XP, Nordson, BeiGene, Lululemon, Walgreens, and Li Auto.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About BeiGene Ltd

Sector

Health Care

Industry

Biotechnology

BeiGene Ltd is a global oncology company that is discovering and developing innovative treatments th...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy BeiGene (BGNE) stock?

You can purchase shares of BeiGene (NASDAQ:BGNE) through any online brokerage.

View our list of the best stock brokerages

Who are BeiGene (BGNE) competitors?

Other companies in BeiGene’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

What is the target price for BeiGene (BGNE) stock?

There is no analysis for BeiGene.

What is the forecast for BeiGene (BGNE) stock?

BeiGene has a consensus price target of $271.46.

Current stock price for BeiGene (BGNE)?

The stock price for BeiGene (NASDAQ: BGNE) is $154.74 last updated July 19, 2024 at 4:00 PM EDT.

Does BeiGene (BGNE) pay a dividend?

There are no upcoming dividends for BeiGene.

When is BeiGene (NASDAQ:BGNE) reporting earnings?

BeiGene’s Q2 earnings are confirmed for Monday, August 5, 2024.

Is BeiGene (BGNE) going to split?

There is no upcoming split for BeiGene.

What sector and industry does BeiGene (BGNE) operate in?

BeiGene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

BeiGene

BeiGene (BGNE) Forecast